Reply to "The Dual Personality of Iron Chelators: Growth Inhibitors or Promoters?"
Overview
Overview
Journal
Antimicrob Agents Chemother
Publisher
American Society for Microbiology
Specialty
Pharmacology
Date
2013 Apr 13
PMID
23580580
Citations
1
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Thompson M, Truong-Le V, Alamneh Y, Black C, Anderl J, Honnold C Antimicrob Agents Chemother. 2015; 59(10):6484-93.
PMID: 26239978 PMC: 4576086. DOI: 10.1128/AAC.00882-15.
References
1.
Visca P, Bonchi C, Minandri F, Frangipani E, Imperi F
. The dual personality of iron chelators: growth inhibitors or promoters?. Antimicrob Agents Chemother. 2013; 57(5):2432-3.
PMC: 3632938.
DOI: 10.1128/AAC.02529-12.
View
2.
Moreau-Marquis S, OToole G, Stanton B
. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol. 2009; 41(3):305-13.
PMC: 2742750.
DOI: 10.1165/rcmb.2008-0299OC.
View
3.
Banin E, Brady K, Greenberg E
. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol. 2006; 72(3):2064-9.
PMC: 1393226.
DOI: 10.1128/AEM.72.3.2064-2069.2006.
View
4.
Thompson M, Corey B, Si Y, Craft D, Zurawski D
. Antibacterial activities of iron chelators against common nosocomial pathogens. Antimicrob Agents Chemother. 2012; 56(10):5419-21.
PMC: 3457357.
DOI: 10.1128/AAC.01197-12.
View
5.
Kuehn B
. Scientists seek antibiotic adjuvants. JAMA. 2011; 306(20):2203-4.
DOI: 10.1001/jama.2011.1709.
View